Evaluation of Safety, PK and Immunomodulatory Effects of AB103 in Necrotizing Soft Tissue Infections Patients
Clinical trial NCT01417780 · COMPLETED
Trial details
- NCT number
- NCT01417780
- Sponsor
- Atox Bio Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2012-09-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.